This week, Dr. Wayne Winegarden, director of PRI's Center for Medical Economics and Innovation, joins us to discuss his new brief exploring how forthcoming restrictions in a state program serving dual-eligible Medicare and Medi-Cal enrollees will hurt patients. He discusses how the movement in government both in California and nationally limiting choice will limit access to care, increase costs to taxpayers and worsen health outcomes.